Effexor and Mirabegron drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Effexor (venlafaxine hydrochloride) and Mirabegron (mirabegron). Common drug interactions include fall among females and device occlusion among males.

The phase IV clinical study analyzes what interactions people have when they take Effexor and Mirabegron. It is created by eHealthMe based on reports of 30 people who take the same drugs from the FDA, and is updated regularly.

What is Effexor?

Effexor has active ingredients of venlafaxine hydrochloride. It is often used in depression. eHealthMe is studying from 99,493 Effexor users. Check the latest studies of Effexor.

What is Mirabegron?

Mirabegron has active ingredients of mirabegron. It is often used in urge incontinence. eHealthMe is studying from 5,414 Mirabegron users. Check the latest studies of Mirabegron.



On Jul, 19, 2026

30 people who take Effexor and Mirabegron together, and have interactions are studied.

Effexor and Mirabegron drug interactions.

What are the common drug interactions of Effexor and Mirabegron, by gender? *:

female:

  1. Fall
  2. Feeling of despair
  3. Multiple sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)
  4. Constipation
  5. Dry mouth
  6. Multiple sclerosis relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)
  7. Ocular icterus (presence of jaundice seen in the sclera of the eye)
  8. Yellow skin
  9. Urinary tract infection
  10. Adverse drug reaction

male:

  1. Device occlusion
  2. Hypotension (abnormally low blood pressure)
  3. Pallor
  4. Parkinson's disease
  5. Rehabilitation therapy
  6. Unresponsive to stimuli

What are the common drug interactions of Effexor and Mirabegron, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Body temperature increased
  2. Heart rate increased
  3. Hypotension (abnormally low blood pressure)
  4. Sjogren's syndrome (a disease that causes dryness in the mouth and eyes)
  5. Tooth disorder (tooth disease)
  6. Trigeminal neuralgia (a painful condition of the nerve responsible for most facial sensation)
  7. Gastrointestinal inflammation (inflammation of stomach and intestine)

40-49:

  1. Anal haemorrhage
  2. Blood pressure increased
  3. Cognitive disorder (mental health disorders affects learning, memory, perception, and problem solving)
  4. Confusional state
  5. Drug ineffective
  6. Dysstasia (difficulty in standing)
  7. Fall
  8. Gait disturbance
  9. Micturition urgency (urgency to pass the urine)
  10. Multiple sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)

50-59:

  1. Hordeolum (small collection of pus (abscess) on the eyelid)
  2. Influenza like illness
  3. Injection site erythema (redness at injection site)
  4. Injection site induration
  5. Injection site mass
  6. Injection site pain
  7. Injection site pruritus (severe itching at injection site)
  8. Injection site reaction
  9. Injection site warmth
  10. Nausea (feeling of having an urge to vomit)

60+:

  1. Constipation
  2. Adverse drug reaction
  3. Movement disorder (neurological syndromes where they may be excess of movement or a paucity of movement that is not connected to weakness)
  4. Muscle disorder (muscle disease)
  5. Muscle spasms (muscle contraction)
  6. Muscle spasticity (tight or stiff muscles and an inability to control those muscles)
  7. Paraparesis (partial paralysis of the lower limbs)
  8. Pharyngeal oedema (abnormal accumulation of fluid in the cavities and intercellular spaces of the pharyngeal)
  9. Psychotic disorder
  10. Renal failure chronic (long lasting kidney dysfunction)

What are the existing conditions these people have? *

  1. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 9 people, 30.00%
  2. Stress And Anxiety: 7 people, 23.33%
  3. Gait Disturbance: 5 people, 16.67%
  4. Hyperlipidaemia (presence of excess lipids in the blood): 5 people, 16.67%
  5. Menopause (end of monthly cycles in women): 4 people, 13.33%
  6. Incontinence (lack of moderation or self-control): 3 people, 10.00%
  7. Hypertonic Bladder (bladder-storage function that causes a sudden urge to urinate): 3 people, 10.00%
  8. Asthma: 3 people, 10.00%
  9. Breast Cancer: 3 people, 10.00%
  10. Constipation: 3 people, 10.00%

* Approximation only. Some reports may have incomplete information.

Do you take Effexor and Mirabegron?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Effexor and Mirabegron:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Effexor:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Mirabegron:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Effexor and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Mirabegron and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on venlafaxine hydrochloride and mirabegron (the active ingredients of Effexor and Mirabegron, respectively), and Effexor and Mirabegron (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: